Free Release of 'Stable Supply Dashboard' Visualizing Supply Performance, Reserve Capacity, and Market Growth Rate of Generic Drugs. Cross-sectional Comparison of 173 Companies and 8,364 Items to Support Stable Supply of Pharmaceuticals
NQ Score
51/100
N1 Content Completeness
9
Key facts
- Free Release of 'Stable Supply Dashboard' Visualizing Supply Performance, Reserve Capacity, and Market Growth Rate of Generic Drugs. Cross-sectional Comparison of 173 Companies and 8,364 Items to Support Stable Supply of Pharmaceuticals
- MiCompany Inc. has released a free 'Stable Supply Dashboard' that visualizes the supply performance, reserve capacity, and market growth rate of generic drugs. It allows cross-sectional comparison of data for 173 companies and 8,364 items, centralizing information from Form 3 and Form 4 based on the Ministry of Health, Labour and Welfare's guidelines. This enables medical institutions, pharmacies, and pharmaceutical manufacturers to comprehensively grasp the stable supply risks of drugs and utilize it for considering alternative drugs and making procurement decisions.
- Source: PR TIMES
- Date: Fri May 29 2026 09:30:01 GMT+0900 (Japan Standard Time)
Direct answer
MiCompany Inc. has released a free 'Stable Supply Dashboard' that visualizes the supply performance, reserve capacity, and market growth rate of generic drugs. It allows cross-sectional comparison of data for 173 companies and 8,364 items, centralizing information from Form 3 and Form 4 based on the Ministry of Health, Labour and Welfare's guidelines. This enables medical institutions, pharmacies, and pharmaceutical manufacturers to comprehensively grasp the stable supply risks of drugs and utilize it for considering alternative drugs and making procurement decisions.
- Citation
- Free Release of 'Stable Supply Dashboard' Visualizing Supply Performance, Reserve Capacity, and Market Growth Rate of Generic Drugs. Cross-sectional Comparison of 173 Companies and 8,364 Items to Support Stable Supply of Pharmaceuticals (Fri May 29 2026 09:30:01 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Fri May 29 2026 09:30:01 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
MiCompany Inc. has released a free 'Stable Supply Dashboard' that visualizes the supply performance, reserve capacity, and market growth rate of generic drugs. It allows cross-sectional comparison of data for 173 companies and 8,364 items, centralizing information from Form 3 and Form 4 based on the Ministry of Health, Labour and Welfare's guidelines. This enables medical institutions, pharmacies, and pharmaceutical manufacturers to comprehensively grasp the stable supply risks of drugs and utilize it for considering alternative drugs and making procurement decisions.
AI Analysis
Frequently Asked Questions
- Q: What is the 'Stable Supply Dashboard'?
- A: It is a free tool that allows cross-sectional confirmation of supply performance, reserve capacity, and market growth rates by efficacy area for generic drugs.
- Q: What data is it based on?
- A: It is based on information published by generic drug manufacturers regarding 'Reserve capacity for stable supply (Form 3)' and 'Supply plans and performance (Form 4)'.
- Q: Is there a fee to use this dashboard?
- A: Basic use is free, but viewing detailed information requires an application via a dedicated form (free of charge).
- Q: Who can utilize this dashboard?
- A: Pharmaceutical manufacturers, drug wholesalers, pharmacy chains, medical institutions, government agencies, and industry associations can utilize it.
- Q: How many items of data are included?
- A: Data for 173 companies and 8,364 items are included.